Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laszlo Endrenyi

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 28, 2009
Regulatory and study conditions for the determination of bioequivalence of highly variable drugsLaszlo Endrenyi, Laszlo Tothfalusi
Journal of Pharmacokinetics and Pharmacodynamics|February 25, 2019
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonizationLaszlo Endrenyi, Laszlo Tothfalusi
The AAPS Journal|August 23, 2012
Metrics for the evaluation of bioequivalence of modified-release formulationsLaszlo Endrenyi, Laszlo Tothfalusi
Omics : a Journal of Integrative Biology|June 15, 2019
A New Approach to Measure Adherence to Medicines Using Biomarkers and SensorsVural Özdemir, Laszlo Endrenyi
Journal of Pharmacokinetics and Pharmacodynamics|March 30, 2019
Panos Macheras: a pioneering scientist in pharmaceutical scienceLaszlo Endrenyi, Robert R Bies
Journal of Biopharmaceutical Statistics|May 25, 2010
Residuals and outliers in replicate design crossover studiesRobert Schall, Laszlo Endrenyi, Arne Ring
British Journal of Clinical Pharmacology|August 23, 2007
Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tabletsLaszlo Tothfalusi, Szilvia Speidl, Laszlo Endrenyi
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 10, 2015
Subsequent Entry Biologics in Canada: Current State of the ScienceLaszlo Endrenyi, Fakhreddin Jamali, Raimar Loebenberg
Clinical Pharmacokinetics|October 13, 2009
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalenceLaszlo Tothfalusi, Laszlo Endrenyi, Alfredo Garcia Arieta
The AAPS Journal|February 4, 2017
The Two Main Goals of Bioequivalence StudiesLaszlo Endrenyi, Henning H Blume, Laszlo Tothfalusi
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 28, 2009
Regulatory and study conditions for the determination of bioequivalence of highly variable drugsLaszlo Endrenyi, Laszlo Tothfalusi
Journal of Pharmacokinetics and Pharmacodynamics|February 25, 2019
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonizationLaszlo Endrenyi, Laszlo Tothfalusi
The AAPS Journal|August 23, 2012
Metrics for the evaluation of bioequivalence of modified-release formulationsLaszlo Endrenyi, Laszlo Tothfalusi
Omics : a Journal of Integrative Biology|June 15, 2019
A New Approach to Measure Adherence to Medicines Using Biomarkers and SensorsVural Özdemir, Laszlo Endrenyi
Journal of Pharmacokinetics and Pharmacodynamics|March 30, 2019
Panos Macheras: a pioneering scientist in pharmaceutical scienceLaszlo Endrenyi, Robert R Bies
Journal of Biopharmaceutical Statistics|May 25, 2010
Residuals and outliers in replicate design crossover studiesRobert Schall, Laszlo Endrenyi, Arne Ring
British Journal of Clinical Pharmacology|August 23, 2007
Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tabletsLaszlo Tothfalusi, Szilvia Speidl, Laszlo Endrenyi
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|July 10, 2015
Subsequent Entry Biologics in Canada: Current State of the ScienceLaszlo Endrenyi, Fakhreddin Jamali, Raimar Loebenberg
Clinical Pharmacokinetics|October 13, 2009
Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalenceLaszlo Tothfalusi, Laszlo Endrenyi, Alfredo Garcia Arieta
The AAPS Journal|February 4, 2017
The Two Main Goals of Bioequivalence StudiesLaszlo Endrenyi, Henning H Blume, Laszlo Tothfalusi
Pageof 4